Last reviewed · How we verify
Pooled allogeneic fecal microbiotherapy — Competitive Intelligence Brief
phase 2
Small molecule
Live · refreshed every 30 min
Target snapshot
Pooled allogeneic fecal microbiotherapy (Pooled allogeneic fecal microbiotherapy) — MaaT Pharma.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Pooled allogeneic fecal microbiotherapy TARGET | Pooled allogeneic fecal microbiotherapy | MaaT Pharma | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Pooled allogeneic fecal microbiotherapy CI watch — RSS
- Pooled allogeneic fecal microbiotherapy CI watch — Atom
- Pooled allogeneic fecal microbiotherapy CI watch — JSON
- Pooled allogeneic fecal microbiotherapy alone — RSS
Cite this brief
Drug Landscape (2026). Pooled allogeneic fecal microbiotherapy — Competitive Intelligence Brief. https://druglandscape.com/ci/pooled-allogeneic-fecal-microbiotherapy. Accessed 2026-06-10.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing